Advancing HIV Therapeutic Vaccine Science (U01)
This Funding Opportunity Announcement (FOA) solicits applications that will advance understanding of vaccine regimens and immune responses that sustainably suppress viral loads in HIV-infected individuals. Applications should propose small, multi-arm, comparative clinical trials designed to identify correlations between levels of induced immune response and HIV virologic control. Vaccines may be combined with adjuvants and/or other modifiers of the immune response to HIV.
Application ProcessApplicants must obtain the SF424 (R&R) application package associated with this funding opportunity using the "Apply for Grant Electronically" button in the FOA or following the directions provided at Grants.gov.